IGMS: IGM Biosciences Inc. Company Short-Term Debt
The production cycle of IGM Biosciences, Inc. (IGMS) relies on automated laboratories, where robotics eliminate errors in the creation of complex biologics. The current level of short-term liabilities stands at 0.00, confirming financial stability following cost optimization and a strategic shift toward autoimmune pathologies. The price visualization available on the page complements the profile of this biotech innovator, which develops unique IgM antibodies to combat cancer.
Metric breakdowns and analytics for IGM Biosciences Inc. (IGMS)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital IGM Biosciences, Inc.|IGMS - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity IGM Bio|IGMS - Company Total Debt|Debt to Book Capitalization Ratio IGM Biosciences, Inc.|IGMS - Company Long-Term Liabilities|Company Current Liabilities IGM Biosciences|Quick Liquidity igmbio.com
- net income and valuation multiples indicators:
Initial company analysis:IGMS - igmbio.com
The development of oncology antibodies by IGM Biosciences, Inc. (IGMS) is independent of economic cycles; therefore, risks are concentrated in R&D and liquidity. The trend in total current liabilities reflects the sum of all debts maturing within one year, allowing investors to conduct a real-time assessment of the company's ability to refinance current debts without compromising scientific trials or capital.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|Upstream Bio Corp - Company Short-Term Debts|Short-Term Debt Volume Zenas Corp ZBIO|IMNM: Company Short-Term Debts|Short-Term Indebtedness gossamerbio.com GOSS|Company Short-Term Debt KalVista Pharmaceuticals, Inc.|Company Current Liabilities Septerna, Inc. (SEPN)|Company Current Liabilities PVLA (Pieris Pharmaceuticals Inc)|SVRA (Savara Pharma) - Company Short-Term Loans and Borrowings|Company Short-Term Debts RIGL (Rigel Pharmaceuticals)|anaptysbio.com - Company Short-Term Debt|Astria Therapeutics, Inc. - Company Short-Term Debts|Short-Term Debt Volume enGene Holdings Inc ENGN|RAPT Therapeutics (RAPT) - Company Short-Term Debt|Short-Term Debt Aerovate Therapeutics (JBIO)|Company Short-Term Debt Aclaris Therapeutics|kyvernatx.com (KYTX) - Short-Term Debt Volume|Company Short-Term Debts TLSA|Company Current Liabilities Cabaletta Bio Inc. CABA|Company Short-Term Debts VTYX (Ventyx Bio)|Short-Term Debt Volume Theratechnologies, Inc (THTX)|Avalo Therapeutics, Inc - Company Short-Term Debts|Short-Term Debt eledon.com|Agenus Inc. (AGEN) - Company Short-Term Debt|Company Short-Term Indebtedness CLYM|ZURA (Zura Bio) - Company Short-Term Debts|Company Current Liabilities aTyr Pharmaceuticals (ATYR)|Company Short-Term Debts ADAG|IMA - Short-Term Debt|Company Short-Term Debt Shattuck Labs STTK|Short-Term Debt Volume Equillium Inc (EQ)|CNTB: Company Current Liabilities|Company Short-Term Loans and Borrowings IMUX (Immunic, Inc.)|ATRA: Company Short-Term Debts|IFRX - Short-Term Debt Volume|Company Short-Term Debt X4 Pharmaceuticals, Inc.|Company Short-Term Indebtedness ACET (Adicet)|Company Short-Term Debts CELU|Company Current Liabilities INmune Bio Corporation INMB|Barinthus Biotherapeutics - Company Current Liabilities|Short-Term Debt Volume kezarlifesciences.com (KZR)|SAB Biotherapeutics, Inc. - Company Short-Term Debts|Short-Term Debt Volume Akari Therapeutics PLC AKTX|ENLV: Company Short-Term Debts|Short-Term Indebtedness Q32 Bio QTTB|Company Short-Term Debt GeoVax Labs, Inc.|Company Current Liabilities edesabiotech.com (EDSA)|Company Short-Term Debt iBio (IBIO)|Short-Term Debt Volume carismatx.com|Company Short-Term Debt XTL Biopharmaceuticals, Ltd. XTLB|BOLT (Bolt Biotherapeutics Inc.) - Current Liabilities|HCW Biologics Inc - Company Short-Term Debts|Company Short-Term Loans and Borrowings APVO (Aptevo Therapeutics)|AIM: Company Short-Term Debts|Aditxt, Inc. (ADTX) - Company Short-Term Debts|Company Short-Term Debt GRI Bio Corp|XRTX: Company Short-Term Loans and Borrowings|Company Short-Term Debt Vyome Holdings Inc (HIND)|Company Current Liabilities revbiosciences.com REVB|Company Short-Term Debts INDP (Indaptus Therapeutics, Inc.)|Company Short-Term Debts Scinai Immunotherapeutics Ltd SCNI|CALI: Company Current Liabilities|Company Short-Term Loans and Borrowings AFMD (Affimed)|ALLK: Company Short-Term Debts|HOOK - Short-Term Debt Volume|Company Short-Term Debt iTeos Therapeutics, Inc.|Company Current Liabilities Ocean Biomedical Inc (OCEA)|Company Short-Term Debt TC BioPharm (Holdings) PLC (TCBP)|Company Current Liabilities Third Harmonic Bio Inc THRD